MDM2 and colonic neoplasm: To assess whether the cooperative actions of MDM2 inhibition and MEK or BRAF inhibition seen in vitro could be translated to the in vivo setting, these agents were orally administered in a pair-wise fashion to mice harboring human RKO colon tumor xenografts (Figure 6).